Waystar Holding Corp(WAY) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:30 PM ET (Korea 9/12 08:30)
Full metrics table
| Index | RUT | P/E | 33.42 | EPS (ttm) | 0.7 | Insider Own | 29.61% | Shs Outstand | 191.9M | Perf Week | -10.01% |
| Market Cap | 4.50B | Forward P/E | 12.5 | EPS next Y | 12.48% | Insider Trans | -0.41% | Shs Float | 135.0M | Perf Month | -4.36% |
| Enterprise Value | 5.76B | PEG | 0.82 | EPS next Q | 0.41 | Inst Own | 88.1% | Short Float | 10.46% | Perf Quarter | 27.21% |
| Income | 0.13B | P/S | 3.73 | EPS this Y | 17.58% | Inst Trans | 4.62% | Short Ratio | 5.3 | Perf Half Y | -4.63% |
| Sales | 1.21B | P/B | 1.13 | EPS next 5Y | 15.23% | ROA | 2.56% | Short Interest | 14.12M | Perf YTD | -28.34% |
| Book/sh | 20.77 | P/C | 20.06 | EPS past 3/5Y | - | ROE | 3.77% | 52W High | -41.83% ($40.35) | Perf Year | -38.8% |
| Cash/sh | 1.17 | P/FCF | 18.27 | Sales past 3/5Y | 15.97% 17.41% | ROIC | 2.47% | 52W Low | 35.98% ($17.26) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | 12.45 | EPS Y/Y TTM | 44.44% | Gross Margin | 56.11% | Volatility(W/M) | 4.16% 4.09% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 4.78 | Sales Y/Y TTM | 19.23% | Oper. Margin | 25.36% | ATR (14) | 1.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.85 | EPS Q/Q | 18.57% | Profit Margin | 11.18% | RSI (14) | 43.97 | Recom | 1.16 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.85 | Sales Q/Q | 18.11% | SMA20 | -5.58% ($24.86) | Beta | 0.26 | Target Price | $33.3 |
| Payout | - | Debt/Eq | 0.37 | Earnings | 2026/7/29 | SMA50 | -1.21% ($23.76) | Rel Volume | 0.65 | Prev Close | $23.06 |
| Employees | 1700 | LT Debt/Eq | 0.37 | EPS/Sales Surpr. | 8.04% 1.1% | SMA200 | -6.28% ($25.04) | Avg Volume(3M) | 2.67M | Price | $23.47 |
| IPO | 2024/6/7 | Option/Short | Yes/Yes | Trades | 31458 | Volume | 1,731,525 | Change | 1.78% |
Company
WAY is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💳 A healthcare technology company that provides medical billing and revenue cycle management software. It automates revenue cycle management for healthcare providers—including billing, insurance claims, and patient payments—through cloud-based software, with a key strength in AI-powered claims processing. The company operates in the medical billing software sector.
Over the past 1 year, roughly in the middle
42% below its 1-year high.
WAY makes money exceptionally well
25.36% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +17.6% this year.
Tap to view numbers
The price looks about right
Trading at 33.4 times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership is about average
Institutions hold 88.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
HEAL 0.03%
BCSM 0.01%
PSCH 0.01%
EKG 0.01%
IPO 0.01%Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
ENOR 180M
NORW 97MIt ranks #4 in the industry
Based on market cap of $5B.
WAY $5B PER 33.4
VEEV $42B PER 43.2
BTSG $12B PER 43.9
TEM $11B PER -
FAQ
What kind of company is WAY?
WAY belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of WAY?
The market cap of WAY is approximately $4.5B, ranking 1,476 within its sector.
What is the P/E ratio of WAY?
WAY has a P/E ratio of approximately 33.4x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for WAY?
WAY has recorded a 52-week high of $40.35 and a low of $17.26.
